By providing your e-mail address, you are consenting to receive press releases, presentations and other information concerning TapImmune. You may withdraw your consent at any time by using our unsubscribe feature.
TapImmune
An immuno-oncology company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease.
